211 related articles for article (PubMed ID: 28214198)
1. Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4.
Chen X; Du Y; Hu Q; Huang Z
Pathol Res Pract; 2017 Mar; 213(3):245-249. PubMed ID: 28214198
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
Chen X; Du Y; Huang Z
Immunol Lett; 2012; 148(1):83-9. PubMed ID: 23000301
[TBL] [Abstract][Full Text] [Related]
3. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
[TBL] [Abstract][Full Text] [Related]
4. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
5. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived CD4+CD25+ Tregs inhibit the maturation and antigen-presenting function of dendritic cells.
Du Y; Chen X; Lin XQ; Wu W; Huang ZM
Asian Pac J Cancer Prev; 2015; 16(7):2665-9. PubMed ID: 25854343
[TBL] [Abstract][Full Text] [Related]
8. Regulation of antigen-expressing dendritic cells by double negative regulatory T cells.
Gao JF; McIntyre MS; Juvet SC; Diao J; Li X; Vanama RB; Mak TW; Cattral MS; Zhang L
Eur J Immunol; 2011 Sep; 41(9):2699-708. PubMed ID: 21660936
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.
Oderup C; Cederbom L; Makowska A; Cilio CM; Ivars F
Immunology; 2006 Jun; 118(2):240-9. PubMed ID: 16771859
[TBL] [Abstract][Full Text] [Related]
10. Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma.
Du Y; Chen X; Huang ZM; Ye XH; Niu Q
Asian Pac J Cancer Prev; 2012; 13(8):3815-9. PubMed ID: 23098476
[TBL] [Abstract][Full Text] [Related]
11. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
[TBL] [Abstract][Full Text] [Related]
12. Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3.
Kowalczyk A; D'Souza CA; Zhang L
Eur J Immunol; 2014 Apr; 44(4):1143-55. PubMed ID: 24338929
[TBL] [Abstract][Full Text] [Related]
13. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.
Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H
J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383
[TBL] [Abstract][Full Text] [Related]
14. Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma.
Song S; Yuan P; Li P; Wu H; Lu J; Wei W
Int Immunopharmacol; 2014 Oct; 22(2):392-9. PubMed ID: 25066760
[TBL] [Abstract][Full Text] [Related]
15. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
[TBL] [Abstract][Full Text] [Related]
16. CD25-expressing Th17 cells mediate CD8
Lang C; Wang J; Chen L
Exp Cell Res; 2017 Nov; 360(2):384-389. PubMed ID: 28942020
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Kawano M; Itonaga I; Iwasaki T; Tsumura H
Oncol Rep; 2013 Mar; 29(3):1001-6. PubMed ID: 23291864
[TBL] [Abstract][Full Text] [Related]
18. Novel immunomodulatory effects of adiponectin on dendritic cell functions.
Tsang JY; Li D; Ho D; Peng J; Xu A; Lamb J; Chen Y; Tam PK
Int Immunopharmacol; 2011 May; 11(5):604-9. PubMed ID: 21094289
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo.
Suarez N; Alfaro C; Dubrot J; Palazon A; Bolaños E; Erro L; Hervas-Stubbs S; Martinez-Forero I; Morales-Kastresana A; Martin-Algarra S; Sangro B; Lecanda F; Perez-Gracia JL; Gonzalez A; Melero I
Int J Cancer; 2011 Jul; 129(2):374-86. PubMed ID: 20853321
[TBL] [Abstract][Full Text] [Related]
20. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study.
Thakur S; Singla A; Chawla Y; Rajwanshi A; Kalra N; Arora SK
Indian J Pathol Microbiol; 2011; 54(3):448-53. PubMed ID: 21934201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
